Neo Ivy Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73M Buy
10,905
+7,145
+190% +$2.17M 1.09% 6
2026
Q1
$803K Buy
3,760
+2,297
+157% +$514K 0.21% 163
2025
Q4
$250K Sell
1,463
-12,047
-89% -$1.87M 0.04% 246
2025
Q3
$1.81M Buy
+13,510
New +$1.43M 0.44% 79
2025
Q2
– Sell
-46,592
Closed -$3.39M – 423
2025
Q1
$3.39M Buy
46,592
+26,678
+134% +$2.1M 1.08% 11
2024
Q4
$1.44M Buy
+19,914
New +$1.51M 0.29% 137
2021
Q1
– Sell
-7,590
Closed -$358K – 571
2020
Q4
$358K Buy
7,590
+4,630
+156% +$195K 0.4% 83
2020
Q3
$98K Buy
+2,960
New +$102K 0.1% 291
2020
Q2
– Sell
-420
Closed -$10K – 535
2020
Q1
$10K Buy
+420
New +$12.1K 0.02% 418
2019
Q4
– Sell
-34,450
Closed -$725K – 342
2019
Q3
$725K Buy
+34,450
New +$723K 0.47% 77
2019
Q1
– Sell
-20,950
Closed -$285K – 354
2018
Q4
$285K Buy
+20,950
New +$300K 0.22% 178

Other funds holding LRCX

Neo Ivy Capital Management's LRCX Position: Q2 2026 in Review

Neo Ivy Capital Management increased its Lam Research (LRCX) stake by 190% in Q2 2026, buying an estimated $2.17M and bringing the position to 10,905 shares worth $4.73M. The position accounts for 1.09% of the portfolio, ranked #6.

Neo Ivy Capital Management first reported a position in LRCX in Q4 2018 and has held it in 11 quarters since. 3,143 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Neo Ivy Capital Management held 10,905 shares of Lam Research worth $4.73M as of Q2 2026.
  • Neo Ivy Capital Management bought 7,145 Lam Research shares in Q2 2026, an estimated $2.17M.
  • Lam Research made up 1.09% of Neo Ivy Capital Management's portfolio in Q2 2026, its #6 holding.
  • Neo Ivy Capital Management first reported a position in Lam Research in Q4 2018 and has held it in 11 quarters since.
  • 3,143 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.